ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access
Amal Ahmed Mohamed1, Nivin Naeem Baiomy2, Abeer M. Rawy3, Mona M.F. Ghanem4, Soha M. Abd El Salam5, Karima Nasraldin6, Mohamed Ramadan Ezz Al Arab7, Hussein H. Samir8, Omar Mohamoud Azzam9, Nashwa M. Muharram10, Naglaa Elsalway11, Ahmed Y. Elamir12, Sarya Swed13, Wael Hafez14, Luis A. Salas-Matta15, Alfonso J. Rodriguez-Morales15-17, D. Katterine Bonilla-Aldana18, Hashem Abu Serhan19, Sanjit Sah20-22 and Rachana Mehta23,24
1Department of Biochemistry and Molecular Biology, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt.
2Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt.
3Chest Diseases, Department of Chest-Faculty of Medicine, Benha University, Benha, Egypt.
4Internal Medicine Department, National Search Center, Cairo, Egypt.
5Department of Medical Microbiology and Immunology, Faculty of Medicine, Suez University, Suez, Egypt.
6Faculty of Biotechnology, Modern Science and Arts University, Giza, Egypt.
7Hepatology and Gastroenterology Department, Ahmed Maher Teaching Hospital, Cairo, Egypt.
8Nephrology Unit, Internal Medicine Department, School of Medicine, Cairo University, Egypt.
9Internal Medicine Department, Ahmed Maher Teaching Hospital, Cairo, Egypt.
10Medical Biochemistry and Molecular Biology, Faculty of Medicine, Menoufia University, Shibin el-Kom, Egypt.
11Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
12Radiology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
13Faculty of Medicine, University of Aleppo, Aleppo, Syria.
14Internal Medicine Department, The National Research Centre, Cairo, Egypt.
15Faculty of Environmental Sciences, Universidad Cientifica del Sur, Lima 4861, Peru.
16Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas-Institucion Universitaria Vision de las Americas, Pereira 660003, Risaralda, Colombia.
17Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanan.
18Research Unit, Universidad Continental, Huancayo, Peru.
19Department of Ophthalmology, Hamad Medical Corporation, Doha, Qatar.
20Department of Paediatrics, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.
21Department of Public Health Dentistry, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.
22SR Sanjeevani Hospital, Kalyanpur, Siraha 56517, Nepal.
23Dr. Lal PathLabs Nepal, Chandol, Kathmandu 44600, Nepal.
24Clinical Microbiology, RDC, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, India.
Article Number: 9700 | © The Author(s). 2024
J Pure Appl Microbiol. 2024;18(4):2688-2702. https://doi.org/10.22207/JPAM.18.4.41
Received: 04 July 2024 | Accepted: 09 September 2024 | Published online: 26 November 2024
Issue online: December 2024
Abstract

Insufficient vitamin D levels in the bloodstream, together with the presence of specific genetic variations known as single nucleotide polymorphisms (SNPs) within the VDR gene, have consistently been linked to a higher likelihood of contracting and experiencing more severe forms of various diseases such as the ongoing COVID-19 pandemic. We aimed to explore the potential relationship between vitamin D levels, Bsml and FOKI polymorphisms, and COVID-19 infection outcomes. A case-control study was conducted with COVID-19 patients and a control group of non-COVID-19 patients (n = 107 each). The associations between vitamin D status, polymorphisms, and COVID susceptibility were investigated. Participants diagnosed with COVID-19 exhibited an average age of 48.84 ± 12.18, while non-COVID-19 patients had an average age of 46.82 ± 9.903. Disease severity, assessed by the CT severity score, showed a negative correlation with the Vitamin D levels. Among participants with COVID-19, the mean level of vitamin D was 35.25 ± 9.40 ng/mL while non-COVID-19 patients showed 38.85 ± 9.40 ng/mL with a significant difference (p = 0.004**) although among COVID-19 cases, 87 (81.3%) individuals had sufficient vitamin D levels and non-severity of disease was more common i.e. 54 (50.5%) among the COVID patients who had sufficient level of Vitamin D. The study found no significant association between Vitamin D levels and rs1544410 Bsml polymorphism (p = 0.429). However, it is important to highlight a weak significant association observed between with Fok1 polymorphism (p = 0.049). These findings underscore the weak influence of genetic factors, particularly VDR Fok1 gene variants, in shaping an individual’s susceptibility to COVID-19. A significant difference in vitamin D status was observed between the COVID-19 and non-COVID-19 groups and lower level was observed in the COVID-19 infected patients. Furthermore, a weak significant association was observed between Fok1 rs2228570 genotype and COVID-19 susceptibility. Larger sample sizes are required to comprehensively understand the association between different genotypes and COVID-19 outcomes.

Keywords

Vitamin D, COVID-19, rs2228750, Fok1, rs1544410, Bsm1, Genotyping Frequency, Alleles Frequency, Genetic Polymorphisms

Article Metrics

Article View: 126

Share This Article

© The Author(s) 2024. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.